Market Overview

Pfizer Expands Clinical Trial Data Access Policy, Launches Data Access Portal

Share:

Pfizer Inc. (NYSE: PFE) today announced an update of its clinical trial
data access policy that will simplify and broaden access to information
gathered in Pfizer-sponsored clinical trials. The updated policy builds
upon and expands the company's established methods of clinical trial
information sharing, including Pfizer's long track record of submitting
for publication results from all interventional clinical trials in
patients and its pioneering efforts to provide clinical trial results
and data to study participants.

Pfizer's updated policy meets or exceeds the “Principles
for Responsible Data Sharing” issued by the Pharmaceutical Research
and Manufacturers of America (PhRMA) and the European Federation of
Pharmaceutical Industries and Associations (EFPIA) in July 2013.

See full press release

Posted-In: News FDA

 

Related Articles (PFE)

View Comments and Join the Discussion!
Fastest Market News Application
You'll Hear It First On Pro
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

UPDATE: Evercore Group Downgrades eBay on Less Expected Potential for Outperformance

UPDATE: William Blair & Company Upgrades Sonic Following Investor Meetings with Management